background: Embryo donation, though less often performed than other assisted reproductive technology (ART), can represent an attractive option for couples who do not wish to discard their embryos remaining after IVF, and for those who cannot or should not conceive naturally. Clinicians and potential participants could benefit from information comparing outcomes of embryo donation with those of other ARTs, in various countries.
Introduction
In 2003, a survey by the RAND Corporation indicated that there were almost 400 000 embryos stored in the USA (Hoffman et al., 2003) . A 2006 survey of 57 Australian fertility clinics reported almost 120 000 frozen embryos in storage (Sullivan et al., 2007) . Significant numbers of cryopreserved embryos also exist in most other developed countries, especially in Europe, where IVF is widely practised.
Patients with embryos remaining after completing IVF treatments sometimes choose to donate those embryos to recipients who are unable to conceive by other methods. Although the date of the world's first live birth resulting from an embryo donation procedure is not documented, several IVF clinics were offering this option to patients in the 1980s (Devroey et al., 1989; M. Bustillo, personal communication, January 2007; H. W. Jones, personal communication, January 2007) . Since 1989, several reports based on small case series have been published, that documented successful pregnancies following the thawing and transfer of donated frozen embryos (Devroey et al., 1989; Asch, 1992; HFEA, 1997; Marcus et al., 1998; Lindheim and Sauer, 1999; Van Voorhis et al., 1999; Sö derströ m-Anttila et al., 2001; Kovacs et al., 2003; Check et al., 2004; Schugars and Daly, 2006) . The report by Asch (1992) was one of the earliest. In this case series, 13 of 17 (76%) donated embryo transfers achieved a pregnancy; the same paper found that pregnancy was achieved in 60% of donor oocyte cycles. The largest of the early series on embryo donation (ED) was published by Check et al. (2004) , and reported pregnancy in 40% of 212 patients using donated embryos.
In the early 2000s, ED for use by infertile women or couples desiring pregnancy was proposed as an alternative disposition for large numbers of frozen embryos, attracting the attention of physicians, attorneys, bioethicists, adoption professionals, policy-makers and the public (Redman and Redman, 2000; Cunningham, 2003; The White House, 2005) . ED may be an option that provides several advantages for some infertile couples seeking to have children; ED is less invasive and time consuming than conventional IVF, often is considerably less expensive than autologous or donor oocyte IVF and may be less expensive than traditional adoption as well (Johnson, 2003; Finger et al., 2010) . In addition, some prospective parents have reported that they are more comfortable having a child who is genetically related to neither parent than to only one parent, as would occur with sperm or oocyte donation (OD; Johnson, 2003) . Finally, ED is one alternative for women or couples who have remaining embryos available but for whom other disposition options are not acceptable. Not all clinics offer ED to their patients, and those that do may have long waiting lists of potential recipients. ED has been chosen by a relatively small percentage of couples with remaining embryos (Nachtigall et al., 2011) , but a recent study showed a higher percentage of patients opting to donate their remaining embryos than had been seen in earlier studies, especially if the embryos had originated from donor oocytes (Hill and Freeman, 2011) .
Those who have frozen embryos in storage or who are considering receiving them, and the physicians responsible for embryo cryopreservation, need reliable data from their respective countries on which to estimate the probability that a donor embryo transfer will result in a live birth, compared with other infertility treatments. We conducted this study to determine the percentage of live births that result from embryo transfer cycles performed in six countries that have national surveillance systems for assisted reproductive technology (ART), and to compare the percentage of live births from donor embryo transfer cycles to that from other ART treatment cycles.
Methods
In this report, we have compiled information on outcomes of ART cycles involving ED, OD, autologous IVF, understood to include ICSI and autologous frozen embryo transfer (FET) for multiple years ranging from 2001 to 2008 from six countries that have national IVF surveillance systems [from which one could extract the data necessary to calculate live birth rate (LBRs) for ED], the USA, Canada, the UK, Australia, New Zealand and Finland. We briefly describe each system and the methods used to obtain the data below. For each of the countries, the unit of analysis is the embryo transfer; therefore, multiple procedures on the same patient are not linked.
United States
In 1996, the US Centers for Disease Control and Prevention (CDC) began to collect data on ART procedures performed in the USA, as mandated by the Fertility Clinic Success Rate and Certification Act of 1992. Data reported electronically by providers to the National ART Surveillance System include patient demographics, medical history and infertility diagnoses, clinical information pertaining to the ART cycle and information regarding resultant pregnancies and births. The data file includes the variable 'source of embryo', which distinguishes ED cycles from other cycles.
The data file is organized with one record per ART procedure performed. For this report, we used data for 2001 -2007 . LBR data, data for multiple birth rates and average numbers of embryos transferred are published on line routinely by the CDC, for IVF, FET and OD. Data specific to ED were supplied to us by CDC staff (listed in the acknowledgements).
Australia/New Zealand
Data from Australia and New Zealand are collected together in one system at the University of New South Wales, Australia; this system has operated in its current form since 
United Kingdom
In the UK, information is collected by the Human Fertilisation and Embryology Authority (HFEA) under a detailed legal mandate. The HFEA regulates and licenses each fertility center and collects and publishes a detailed national summary of information on each type of fertility treatment (HFEA, 2006) . 
Canada
Information is collected in the Canadian Assisted Reproduction Technologies Register. This surveillance system has operated since 1999 and publishes an annual report, including detailed methods, in Fertility and Sterility (Gunby et al., 2010) 
Data analysis
We obtained from each country the numbers of donated embryo transfers (ED), autologous embryo transfers (fresh i.e. IVF or frozen i.e. FET) and transfers of embryos resulting from donor oocytes (fresh or frozen) for the specified years, as well as the outcomes (live birth or other). We determined the percent of transfers resulting in at least one live birth by treatment type for each country, which we will refer to as the LBR. This was calculated as the number of deliveries with at least one live infant, divided by the number of embryo transfer cycles. We calculated the relative risk (RR) of live birth for each of the treatment types, using IVF as a reference. We also calculated 95% confidence intervals for these RRs using an easily available on-line statistical program (Hutchon, 2011) . For the countries and treatment types for which the average number of embryos per transfer procedure was available, we calculated the LBR per embryo transferred by dividing the LBR by the average number of embryos transferred. This was to evaluate the extent to which differences in the average number of embryos transferred, whether these happen by physician choice, patient preference or circumstances (the number of available embryos), might affect the live birth delivery rates. As an additional exercise, we performed the age adjustment where data were available to do so (USA, UK and Australia/New Zealand) to see if differences in the age distribution of patients made any significant difference. Since we found that it made little to no difference, we have not included these findings in the report. In addition, multiple birth rates (percentages of all live births that are multiples) were calculated for countries with data available (USA, Canada and Australia/New Zealand).
Results
For each country and each type of embryo transfer, Table I shows the number of transfer procedures, number of live birth deliveries, the LBR and the average number of embryos transferred per procedure, for ED, IVF, autologous FET and transfers from ODs (fresh and frozen). LBRs ranged from 22 to 35% for IVF, 16 to 28% for FET, 15 to 52% for fresh and frozen transfers from donor oocytes and 14 to 33% for ED. In every country except Australia/New Zealand, as well as for all countries combined, the LBR for ED was similar to that for IVF. In Finland and Canada, the difference did not achieve significance (see Table I ). LBRs were higher for ED than for (autologous) FET except in Australia/New Zealand. The average number of embryos per transfer ranged from 1.5 to 2.8 among the countries. Australia/New Zealand and Finland averaged fewer embryos per transfer than the USA, the UK and Canada. These varied little across treatment type within each country. The countries with lower average numbers of embryos transferred also had, in general, lower LBRs. Using the LBR per embryo transferred (not shown in table) reduced, but did not eliminate the differences among countries. The LBR per embryo transferred ranged from 11 to 12% for donor embryo cycles, 8 to 11% for autologous FET, 12 to 15% for autologous IVF and 9 to 21% for OD.
Data were available to compare multiple birth rates among the treatment types for the USA, Canada and Australia/New Zealand (Table II) . The multiple birth rates were higher in the USA than elsewhere, a finding not surprising given that the average number of embryos transferred in the USA was higher.
Discussion
This paper provides the largest summary of data on outcomes from transfers of fresh or frozen donated embryos published to date. For all countries included in this analysis, ED LBRs compare favorably with most other forms of ART. Within any given country, clinics performing most of the donated transfers may be larger and more experienced than other clinics, and this would be expected to contribute to favorable rates. For the USA, Canada and Finland, LBRs resulting from ED also compare favorably with that from autologous IVF. Although the RR of LBR is technically lower at 0.95 for the USA and 0.90 for all countries combined, this difference may be more significant statistically than clinically. The reason for these high LBRs from donated embryos is likely due in part to the quality of embryos available, given that pregnancy has usually already been achieved in fresh IVF cycles by couples donating their remaining frozen embryos. This factor could exist despite the possibility that the morphologically best embryos in a group had already been used in the fresh transfer. In addition, some donated embryos were originally made with an oocyte from a donor, which would give them, on average, a better chance at implantation. We also cannot exclude the possibility that couples who seek to receive donated embryos may have other biologic factors that are not associated with the embryo or its genetics. Hence, using donated embryos could give them a slight advantage over couples receiving their own FET. Furthermore, some couples who opt to receive donated embryos have either no infertility factors, or conditions which would not be expected to interfere with embryo implantation, whereas it is likely that some infertile couples going through autologous IVF may have these factors. The data we have available do not permit specific assessment of these variables.
The reasons for international variation in outcomes of ED and other ART treatments are largely unknown. Characteristics of national data collection systems, such as being voluntary or mandatory, participation rate, linkage to national reimbursement system, the extent to which reported data are verified and existence of statistical quality assurance systems, can explain the variation in completeness and validity of national ART statistics, and may in part explain some of the variation seen between countries as well. There is, however, no information on the international comparability of ART statistics, including data on EDs. It can be seen in Table I that the LBRs are higher in Canada and the USA than in the other countries, and that the differences among countries are relatively consistent from one treatment type to another. Different legislative requirements for ED, health care practices, provider training and available laboratory techniques and supplies may contribute to the observed differences. The countries with lower average numbers of embryos transferred also had, in general, lower LBRs. Some countries with well-established systems for FETs after IVF/ICSI treatments tend to transfer fewer embryos, but their cumulative pregnancy and live birth rates are similar to other countries (Tiitinen, 2009 ).
We were not able to assess the impact of increasing use of FET with our data, even though we know that countries have different policies governing how widely FET is used, and that the practice became substantially more common in some countries during our 8-year study period. However, the live birth delivery percent per embryo transferred still varies enough among countries to suggest that other factors must influence the rate differences.
Clearly, this report has several limitations, one of which is the limited number of countries from which national surveillance data are available; although we have no reason to suspect that results would vary, the extent to which our results may be generalizable to other countries is unknown. In addition, we have only limited information about patient characteristics and the national systems from which we collected the data, and hence cannot fully address possible reasons for observed differences in outcomes. For instance, the available data do not permit us to assess the impact of cryopreservation techniques on the LBRs. However, the outcomes would be expected to improve in the future, as experience and techniques are further refined.
The outcome rates presented in this paper provide evidence that ART procedures using donated embryos provide a viable option for many couples to achieve pregnancy. However, one US medical center conducted a retrospective review of data from 2002 to mid-2007 and reported that only 3% of couples chose to donate their remaining frozen embryos for use by other couples (Lanzendorf et al., 2010) . Clinicians should discuss all available options with patients who have remaining cryopreserved embryos that they do not wish to use, including the option of ED. Clinicians who practice in centers where ED is not available may be able to refer interested patients to centers that do offer this. As the practice of ED becomes more common, it will be important to continue evaluating its outcomes, and to conduct further research into the medical, epidemiologic and social welfare issues involved. The studies should include donors, treated couples/women and children born after these treatments. 
